MCLEAN, Va., Feb. 16 /PRNewswire-FirstCall/ -- MicroStrategy(R) Incorporated , a leading worldwide provider of business intelligence software, today announced that following an open public procurement procedure, the European Medicines Agency has chosen the MicroStrategy Business Intelligence Platform(TM) as its enterprise business intelligence standard. The purchase of MicroStrategy’s software and services is valued at approximately $3 million.
European Medicines Agency (EMEA), based in London, is a decentralized agency that serves to protect and promote public and animal health through the evaluation and supervision of medicines for human and veterinary use. The EMEA has a coordinating role in the evaluation and supervision of medicinal products throughout the European Union (EU) using the scientific resources of the 25 EU Member States and the three additional European Economic Area States in a network of 42 national competent authorities.
More than 40,000 users including regulators, pharmaceutical companies and health care professionals analyze safety information for drugs before and after they are introduced to the market. The MicroStrategy reporting and analysis applications will be used for the EudraVigilance database and will access pharmacovigilance data residing in an Oracle(R) data warehouse.
“The European Medicines Agency is investing in MicroStrategy business intelligence to enhance the analyses we perform to monitor the safety of medicinal products supplied to the whole of the European Union,” said Dr. Hans-Georg Wagner, Head of Unit for Communications and Networking, European Medicines Agency. “We chose MicroStrategy through an open public procurement procedure for business intelligence products appropriate for monitoring drug safety information, because we concluded that MicroStrategy will provide us with the best solution for our needs.”
“We are pleased that the European Medicines Agency selected MicroStrategy for agency-wide reporting and analysis,” said Sanju Bansal, COO of MicroStrategy. “This deal reflects the value that MicroStrategy-based reporting, analysis, and monitoring can provide public sector organizations. We look forward to supporting the European Medicines Agency in its business intelligence endeavors.”
About European Medicines Agency
The European Medicines Agency (EMEA) is a decentralized body of the European Union with headquarters in London. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use. The EMEA coordinates the evaluation and supervision of medicinal products throughout the European Union. The EMEA has a coordinating role in the evaluation and supervision of medicinal products throughout the European Union (EU). The Agency uses the scientific resources of the 25 EU Member States and the 3 European Economic Area States in a network of 42 national competent authorities. It cooperates closely with international partners, reinforcing the EU contribution to global harmonization. A network of some 3,500 European experts underpins the scientific work of the EMEA and its committees.
About MicroStrategy
Founded in 1989, MicroStrategy is a worldwide leader in the business intelligence software market. Leading Fortune 2000 companies are integrating MicroStrategy’s business monitoring, reporting, and analysis software into their operations. The MicroStrategy Business Intelligence Platform(TM) distills vast amounts of data into vital insight to help drive cost- efficiency, revenue-generation, and productivity. Top companies are using MicroStrategy to cost-effectively empower thousands of employees, partners, and suppliers with the business insight they need to make better business decisions everyday.
MicroStrategy has over 2,800 enterprise-class customers, including Aventis, eBay, General Motors, Lowe’s Companies, Pfizer, Sprint, Telecom Italia, U.S. Postal Service, Visa International, Wells Fargo, and Yahoo!. MicroStrategy also has relationships with over 300 systems integrators and application development and platform partners, including HP, IBM, PeopleSoft, Sun, and Teradata, a division of NCR. MicroStrategy is listed on Nasdaq under the symbol MSTR. For more information or to purchase or demo MicroStrategy’s software, visit MicroStrategy’s Web site at http://www.microstrategy.com/.
MicroStrategy, MicroStrategy 7, MicroStrategy 8, MicroStrategy Business Intelligence Platform, MicroStrategy Report Services, and MicroStrategy 7i are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.
This press release may include statements that may constitute “forward- looking statements,” including its estimates of future business prospects or financial results and statements containing the words “believe,” “estimate,” “project,” “expect” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results of MicroStrategy Incorporated and its subsidiaries (collectively, the “Company”) to differ materially from the forward-looking statements. Factors that could contribute to such differences include: the ability of the Company to implement and achieve widespread customer acceptance of its MicroStrategy 8 software on a timely basis; the Company’s ability to recognize deferred revenue through delivery of products or satisfactory performance of services; continued acceptance of the Company’s products in the marketplace; the timing of significant orders; delays in the Company’s ability to develop or ship new products; market acceptance of new products; competitive factors; general economic conditions; currency fluctuations; and other risks detailed in the Company’s registration statements and periodic reports filed with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
CONTACT: Wende Cover of MicroStrategy Incorporated, +1-703-770-1646, or wcover@microstrategy.com.
MicroStrategy Incorporated
CONTACT: Wende Cover of MicroStrategy Incorporated, +1-703-770-1646, orwcover@microstrategy.com
Web site: http://www.microstrategy.com/